Free Trial

Aster Capital Management DIFC Ltd Has $30,000 Stock Holdings in Perrigo Company plc (NYSE:PRGO)

Perrigo logo with Medical background
Remove Ads

Aster Capital Management DIFC Ltd trimmed its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 91.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,168 shares of the company's stock after selling 12,228 shares during the quarter. Aster Capital Management DIFC Ltd's holdings in Perrigo were worth $30,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in PRGO. Franklin Resources Inc. bought a new position in shares of Perrigo in the 3rd quarter valued at approximately $3,717,000. Barclays PLC boosted its holdings in shares of Perrigo by 44.8% during the 3rd quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after buying an additional 37,268 shares during the period. JPMorgan Chase & Co. grew its stake in Perrigo by 65.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock valued at $14,190,000 after buying an additional 213,221 shares during the last quarter. Virtu Financial LLC bought a new position in Perrigo in the 3rd quarter worth $909,000. Finally, Access Investment Management LLC bought a new stake in Perrigo during the fourth quarter valued at about $7,989,000. Institutional investors own 95.91% of the company's stock.

Perrigo Stock Performance

Shares of PRGO traded up $0.01 on Tuesday, reaching $25.01. 146,126 shares of the stock traded hands, compared to its average volume of 1,521,787. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The stock's 50-day moving average price is $26.43 and its 200-day moving average price is $26.06. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of -21.31 and a beta of 0.49.

Remove Ads

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. The business had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Equities analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were paid a dividend of $0.29 per share. This is a positive change from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a yield of 4.64%. The ex-dividend date of this dividend was Friday, March 7th. Perrigo's dividend payout ratio is currently -92.80%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on PRGO. Piper Sandler cut Perrigo from an "overweight" rating to a "neutral" rating and cut their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com cut Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Finally, Argus lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Perrigo has an average rating of "Hold" and an average price target of $33.00.

Read Our Latest Report on PRGO

Insider Transactions at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.70% of the stock is owned by insiders.

Perrigo Company Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads